Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Plasma Eye Drops for Neuropathic Corneal Pain
NCT07566806Recruiting
- Sponsor
- Singapore Eye Research Institute
- Start
- Sep 2023
- Primary completion
- Sep 2026
- Modality
- Biologic
- Countries
- 1
01
Overview
Open-label, single-arm trial of cord plasma eye drops in neuropathic corneal pain (NCP), sponsored by Singapore Eye Research Institute. Primary endpoints: Ocular Pain Assessment Survey at 3 months and Corneal nerve morphology assessment by in vivo confocal microscopy (IVCM) at 3 months. Started Sep 2023; status: recruiting.
02
Drugs
cord plasma eye drops
03
Conditions
neuropathic corneal pain (NCP)
Beyond the preview
Go deeper on NCT07566806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07566806.